Jacksonville, FL

Research output

Research output per year 1967 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

• 13572 Article
• 1961 Review article
• 718 Letter
• 640 Comment/debate
• 1059 More
  • 419 Chapter
  • 381 Editorial
  • 137 Short survey
  • 66 Conference contribution
  • 23 Foreword/postscript
  • 20 Book
  • 11 Conference article
  • 2 Paper

Research output per year

Research output per year

Search results

• 2024

  Aberrant TIMP-1 production in tumor-associated fibroblasts drives the selective benefits of nintedanib in lung adenocarcinoma

  Duch, P., Díaz-Valdivia, N., Gabasa, M., Ikemori, R., Arshakyan, M., Fernández-Nogueira, P., Llorente, A., Teixido, C., Ramírez, J., Pereda, J., Chuliá-Peris, L., Galbis, J. M., Hilberg, F., Reguart, N., Radisky, D. C. & Alcaraz, J., 2024, (Accepted/In press) In: Cancer Science.

  Research output: Contribution to journal › Article › peer-review

  Open Access

• Acute esophageal stricture after bone marrow transplant

  Pang, S., Saleh, H., Ailawadhi, S., Edgar, M. & Pang, M., Feb 2024, In: Clinical Journal of Gastroenterology. 17, 1, p. 1-5 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Esophageal Stenosis 100%
  • Bone Marrow Transplantation 78%
  • Bone Marrow 56%
  • Transplants 47%
  • Triamcinolone 25%

• Alfred Washington Adson: Perspectives on Intracranial Neurosurgery and the Responsibilities of the Neurosurgeon

  Nguyen, B. A., Parikh, P. P., Nguyen, A., Singh, R., Stonnington, H. O., Bendok, B. R., Quinones-Hinojosa, A., Spinner, R., Meyer, F. & Bydon, M., Apr 1 2024, In: Neurosurgery. 94, 4, p. 875-881 7 p.

  Research output: Contribution to journal › Article › peer-review

• A new initiative for the Journal of the National Cancer Institute: supporting early career investigators

  Sherman, M. E., Boehm, A. L. & Franco, E. L., Mar 1 2024, In: Journal of the National Cancer Institute. 116, 3, p. 341-342 2 p.

  Research output: Contribution to journal › Editorial › peer-review

  Open Access

• An international, multispecialty, expert-based Delphi Consensus document on controversial issues in the management of patients with asymptomatic and symptomatic carotid stenosis

  Paraskevas, K. I., Mikhailidis, D. P., Ringleb, P. A., Brown, M. M., Dardik, A., Poredos, P., Gray, W. A., Nicolaides, A. N., Lal, B. K., Mansilha, A., Antignani, P. L., de Borst, G. J., Cambria, R. P., Loftus, I. M., Lavie, C. J., Blinc, A., Lyden, S. P., Matsumura, J. S., Jezovnik, M. K., Bacharach, J. M., & 41 othersMeschia, J. F., Clair, D. G., Zeebregts, C. J., Lanza, G., Capoccia, L., Spinelli, F., Liapis, C. D., Jawien, A., Parikh, S. A., Svetlikov, A., Menyhei, G., Davies, A. H., Musialek, P., Roubin, G., Stilo, F., Sultan, S., Proczka, R. M., Faggioli, G., Geroulakos, G., Fernandes e Fernandes, J., Ricco, J. B., Saba, L., Secemsky, E. A., Pini, R., Myrcha, P., Rundek, T., Martinelli, O., Kakkos, S. K., Sachar, R., Goudot, G., Schlachetzki, F., Lavenson, G. S., Ricci, S., Topakian, R., Millon, A., Di Lazzaro, V., Silvestrini, M., Chaturvedi, S., Eckstein, H. H., Gloviczki, P. & White, C. J., Feb 2024, In: Journal of vascular surgery. 79, 2, p. 420-435.e1

  Research output: Contribution to journal › Review article › peer-review

• An Open-Label Phase I Study of Metformin and Nelfinavir in Combination With Bortezomib in Patients With Relapsed and Refractory Multiple Myeloma

  Alodhaibi, I., Ailawadhi, S., Burbano, G. P., O'Brien, P. J., Buadi, F. K., Hayman, S., Kumar, S. K. & Gonsalves, W. I., 2024, (Accepted/In press) In: Clinical Lymphoma, Myeloma and Leukemia.

  Research output: Contribution to journal › Article › peer-review

  • Nelfinavir 100%
  • Bortezomib 82%
  • Metformin 72%
  • Multiple Myeloma 66%
  • Safety 10%

• A novel mechanoeffector role of fibroblast S100A4 in myofibroblast transdifferentiation and fibrosis

  Southern, B. D., Li, H., Mao, H., Crish, J. F., Grove, L. M., Scheraga, R. G., Mansoor, S., Reinhardt, A., Abraham, S., Deshpande, G., Loui, A., Ivanov, A. I., Rosenfeld, S. S., Bresnick, A. R. & Olman, M. A., Jan 2024, In: Journal of Biological Chemistry. 300, 1, 105530.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Myofibroblasts 100%
  • Disorder 74%
  • Myosin Type II 72%
  • Fibrosis 64%
  • Fibroblasts 64%

• Antihypertensive Pharmacotherapy for Patients Undergoing Carotid Revascularization

  Turan, T. N., Lal, B. K. & Meschia, J. F., Apr 2024, In: Annals of Vascular Surgery. 101, p. 193-194 2 p.

  Research output: Contribution to journal › Letter › peer-review

• A phase 1b open-label study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of py314 in combination with pembrolizumab in patients with advanced renal cell carcinoma

  Beckermann, K. E., Patnaik, A., Winer, I., Tan, W., Bashir, B., Kyriakopoulos, C. E., Sweis, R. F., Chamberlain, M. & Rini, B. I., Apr 2024, In: Investigational New Drugs. 42, 2, p. 179-184 6 p.

  Research output: Contribution to journal › Article › peer-review

• A phase II study of ibrutinib in combination with ixazomib in patients with Waldenström macroglobulinaemia

  Parrondo, R. D., Dutta, N., LaPlant, B. R., Elliott, J., Fernandez, A., Zimmerman, A., Cicco, G., Han, B., Heslop, K., Chapin, D., Sher, T., Roy, V., Rasheed, A., Das, S., Chanan-Khan, A. A., Paulus, A. & Ailawadhi, S., 2024, (Accepted/In press) In: British journal of haematology.

  Research output: Contribution to journal › Article › peer-review

  • ixazomib 100%
  • PCI 32765 85%
  • Waldenstrom Macroglobulinemia 78%
  • Progression-Free Survival 34%
  • Proteasome Endopeptidase Complex 19%

• Application of Global Lung Function Initiative Global Spirometry Reference Equations across a Large, Multicenter Pulmonary Function Lab Population

  Kanj, A. N., Scanlon, P. D., Yadav, H., Smith, W. T., Herzog, T. L., Bungum, A., Poliszuk, D., Fick, E., Lee, A. S. & Niven, A. S., Jan 1 2024, In: American journal of respiratory and critical care medicine. 209, 1, p. 83-90 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

• A prospective study of the relationship between illness perception, depression, anxiety, and quality of life in hematopoietic stem cell transplant patients

  Ames, S. C., Lange, L., Ames, G. E., Heckman, M. G., White, L. J., Roy, V. & Foran, J. M., Feb 2024, In: Cancer medicine. 13, 3, e6906.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Hematopoietic Stem Cell Transplantation 100%
  • Hematopoietic Stem Cells 92%
  • Anxiety 67%
  • Depression 61%
  • Quality of Life 60%

• A real-world experience of pembrolizumab monotherapy in microsatellite instability-high and/or tumor mutation burden-high metastatic castration-resistant prostate cancer: outcome analysis

  Mosalem, O., Tan, W., Bryce, A. H., Dronca, R. S., Childs, D. S., Pagliaro, L. C., Orme, J. J. & Kase, A. M., 2024, (Accepted/In press) In: Prostate Cancer and Prostatic Diseases.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • pembrolizumab 100%
  • Microsatellite Instability 87%
  • Castration 78%
  • Tumor Burden 67%
  • Prostatic Neoplasms 56%

• Artificial microRNA suppresses C9ORF72 variants and decreases toxic dipeptide repeat proteins in vivo

  Cabrera, G. T., Meijboom, K. E., Abdallah, A., Tran, H., Foster, Z., Weiss, A., Wightman, N., Stock, R., Gendron, T., Gruntman, A., Giampetruzzi, A., Petrucelli, L., Brown, R. H. & Mueller, C., Mar 2024, In: Gene Therapy. 31, 3-4, p. 105-118 14 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Chromosomes, Human, Pair 9 100%
  • Dipeptides 97%
  • Open Reading Frames 72%
  • MicroRNAs 63%
  • Poisons 56%

• A seizure in the eye of the beholder: painting an absence-to-bilateral-tonic–clonic seizure

  Barrios, M. S., Rainey, C. & Feyissa, A. M., Apr 2024, In: Neurological Sciences. 45, 4, p. 1799-1801 3 p.

  Research output: Contribution to journal › Article › peer-review

• Assessment of second primary malignancies among treated and untreated patients with chronic lymphocytic leukemia using real-world data from the USA

  Ailawadhi, S., Ravelo, A., Ng, C. D., Shah, B., Lamarre, N., Wang, R., Eakle, K. & Biondo, J. M., Feb 1 2024, In: Journal of Comparative Effectiveness Research. 13, 2, p. e230119

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • chronic lymphocytic leukemia 100%
  • Second Primary Neoplasms 58%
  • B-Cell Chronic Lymphocytic Leukemia 54%
  • Medicare Part B 11%
  • health maintenance organizations 10%

• Association between cognitive impairment and antiseizure medication adherence among people with epilepsy in Addis Ababa, Ethiopia

  Mamo, B., Feyissa, A. M., Mengesha, T., Ayele, B. A. & Mamushet Yifru, Y., Mar 2024, In: Epilepsy and Behavior. 152, 109651.

  Research output: Contribution to journal › Article › peer-review

  • Ethiopia 100%
  • Medication Adherence 94%
  • Epilepsy 71%
  • Cognitive Dysfunction 70%
  • Exercise 20%

• A study to assess the efficacy of enasidenib and risk-adapted addition of azacitidine in newly diagnosed IDH2-mutant AML

  Cai, S. F., Huang, Y., Lance, J. R., Mao, H. C., Dunbar, A. J., McNulty, S. N., Druley, T., Li, Y., Baer, M. R., Stock, W., Kovacsovics, T., Blum, W. G., Schiller, G. J., Olin, R. L., Foran, J. M., Litzow, M., Lin, T., Patel, P., Foster, M. C., Boyiadzis, M., & 18 othersCollins, R. H., Chervin, J., Shoben, A., Vergilio, J. A., Heerema, N. A., Rosenberg, L., Chen, T. L., Yocum, A. O., Druggan, F., Marcus, S., Stefanos, M., Druker, B. J., Mims, A. S., Borate, U., Burd, A., Byrd, J. C., Levine, R. L. & Stein, E. M., Jan 23 2024, In: Blood Advances. 8, 2, p. 429-440 12 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • AG-221 100%
  • Isocitrate Dehydrogenase 70%
  • Azacitidine 68%
  • Acute Myeloid Leukemia 49%
  • Therapeutics 8%

• Asymptomatic Females Are at Higher Risk for Perioperative TIA/Stroke and Males Are at Higher Risk for Long-Term Mortality after Carotid Artery Stenting: A Vascular Quality Initiative Analysis

  Erben, Y., Li, Y., Da Rocha-Franco, J. A., Tawk, R. G., Barrett, K. M., Freeman, W. D., Lin, M., Huang, J. F., Miller, D., Farres, H., Brott, T. G., Meschia, J. F. & Hakaim, A. G., Feb 12 2024, In: International Journal of Angiology. 33, 1, p. 36-45 10 p.

  Research output: Contribution to journal › Article › peer-review

  • Transient Ischemic Attack 100%
  • Carotid Arteries 88%
  • Stroke 62%
  • Blood Vessels 53%
  • Mortality 45%

• Author Correction: Central role for PICALM in amyloid-β blood-brain barrier transcytosis and clearance (Nature Neuroscience, (2015), 18, 7, (978-987), 10.1038/nn.4025)

  Zhao, Z., Sagare, A. P., Ma, Q., Halliday, M. R., Kong, P., Kisler, K., Winkler, E. A., Ramanathan, A., Kanekiyo, T., Bu, G., Owens, N. C., Rege, S. V., Si, G., Ahuja, A., Zhu, D., Miller, C. A., Schneider, J. A., Maeda, M., Maeda, T., Sugawara, T., & 2 othersIchida, J. K. & Zlokovic, B. V., Jan 2024, In: Nature Neuroscience. 27, 1, p. 208 1 p.

  Research output: Contribution to journal › Comment/debate › peer-review

  Open Access

  • Transcytosis 100%
  • Neurosciences 80%
  • Microvessels 75%
  • Blood-Brain Barrier 72%
  • Amyloid 70%

• Autoimmune Hepatitis: A Diagnostic and Therapeutic Overview

  Mercado, L. A., Gil-Lopez, F., Chirila, R. M. & Harnois, D. M., Feb 2024, In: Diagnostics. 14, 4, 382.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Azathioprine 100%
  • Autoimmune Hepatitis 77%
  • Mycophenolate Mofetil 53%
  • Adrenal Cortex Hormone 39%
  • Aspartate 33%

• Autologous cell immunotherapy (IGV-001) with IGF-1R antisense oligonucleotide in newly diagnosed glioblastoma patients

  Lee, I. Y., Hanft, S., Schulder, M., Judy, K. D., Wong, E. T., Elder, J. B., Evans, L. T., Zuccarello, M., Wu, J., Aulakh, S., Agarwal, V., Ramakrishna, R., Gill, B. J., Quiñones-Hinojosa, A., Brennan, C., Zacharia, B. E., Silva Correia, C. E., Diwanji, M., Pennock, G. K., Scott, C., & 3 othersPerez-Olle, R., Andrews, D. W. & Boockvar, J. A., Mar 1 2024, In: Future oncology (London, England). 20, 10, p. 579-591 13 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

• Awake brain mapping paradigms for nondominant hemisphere gliomas

  Ekert, J. O., Sabsevitz, D. S., del Campo, I. M., Goyal, A., Gillespie, C. S., Middlebrooks, E. H., Chaichana, K. L., Lee, K. S., Sanchez-Garavito, J. E. & Quiñones-Hinojosa, A., 2024, In: Neurosurgical focus. 56, 2, E7.

  Research output: Contribution to journal › Article › peer-review

  • Brain Mapping 100%
  • Glioma 67%
  • Language 57%
  • Cognition 34%
  • Craniotomy 32%

• Awake Craniotomy Program Implementation

  Moniz-Garcia, D., Bojaxhi, E., Borah, B. J., Dholakia, R., Kim, H., Sousa-Pinto, B., Almeida, J. P., Mendhi, M., Freeman, W. D., Sherman, W., Christel, L., Rosenfeld, S., Grewal, S. S., Middlebrooks, E. H., Sabsevitz, D., Gruenbaum, B. F., Chaichana, K. L. & Quiñones-Hinojosa, A., Jan 24 2024, In: JAMA Network Open. 7, 1, p. E2352917

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Craniotomy 100%
  • Costs and Cost Analysis 42%
  • Length of Stay 34%
  • Mortality 17%
  • Patient Readmission 13%

• Benign Breast Disease and Breast Cancer Risk in the Percutaneous Biopsy Era

  Sherman, M. E., Vierkant, R. A., Winham, S. J., Vachon, C. M., Carter, J. M., Pacheco-Spann, L., Jensen, M. R., McCauley, B. M., Hoskin, T. L., Seymour, L., Gehling, D., Fischer, J., Ghosh, K., Radisky, D. C. & Degnim, A. C., Feb 14 2024, In: JAMA surgery. 159, 2, p. 193-201 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Breast Diseases 100%
  • Breast Neoplasms 51%
  • Biopsy 48%
  • Carcinoma, Intraductal, Noninfiltrating 20%
  • Hyperplasia 20%

• Biomarker-based staging of Alzheimer disease: rationale and clinical applications

  Therriault, J., Schindler, S. E., Salvadó, G., Pascoal, T. A., Benedet, A. L., Ashton, N. J., Karikari, T. K., Apostolova, L., Murray, M. E., Verberk, I., Vogel, J. W., La Joie, R., Gauthier, S., Teunissen, C., Rabinovici, G. D., Zetterberg, H., Bateman, R. J., Scheltens, P., Blennow, K., Sperling, R., & 3 othersHansson, O., Jack, C. R. & Rosa-Neto, P., Apr 2024, In: Nature Reviews Neurology. 20, 4, p. 232-244 13 p.

  Research output: Contribution to journal › Review article › peer-review

  • Alzheimer Disease 100%
  • Biomarkers 83%
  • Amyloid 81%
  • Molecular Imaging 25%
  • Clinical Decision-Making 22%

• Bone morphogenic protein-4 availability in the cardiac microenvironment controls inflammation and fibrosis in autoimmune myocarditis

  Perez-Shibayama, C., Gil-Cruz, C., Cadosch, N., Lütge, M., Cheng, H. W., De Martin, A., Frischmann, K., Joachimbauer, A., Onder, L., Papadopoulou, I., Papadopoulou, C., Ring, S., Krebs, P., Vu, V. P., Nägele, M. P., Rossi, V. A., Parianos, D., Zsilavecz, V. W., Cooper, L. T., Flammer, A., & 4 othersRuschitzka, F., Rainer, P. P., Schmidt, D. & Ludewig, B., Mar 2024, In: Nature Cardiovascular Research. 3, 3, p. 301-316 16 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Myocarditis 100%
  • Neutralization 89%
  • Fibrosis 65%
  • Heart Failure 65%
  • Cardiac Myocytes 55%

• Chemoimmunotherapy for Untreated Lung Cancer Brain Metastases: A Reason for Optimism While Avoiding Overreaching Interpretations

  Lehrer, E. J., Trifiletti, D. M., Fadul, C. E., Brown, P. D. & Sheehan, J. P., Mar 1 2024, In: Journal of Clinical Oncology. 42, 7, p. 857-858 2 p.

  Research output: Contribution to journal › Letter › peer-review

• Circadian rhythm and whole gut transit in mice

  Laible, E., Wegner, A., Knutson, K., Kacmaz, H., Garramone, G. K., Gogineni, K., Matveyenko, A., Linden, D. R., Farrugia, G. & Beyder, A., Apr 2024, In: Neurogastroenterology and Motility. 36, 4, e14771.

  Research output: Contribution to journal › Article › peer-review

  • Circadian Rhythm 100%
  • Carmine 40%
  • Gastrointestinal Transit 22%
  • Photoperiod 20%
  • Light 16%

• Clinical and genetic predictors of cardiac dysfunction assessed by echocardiography in patients with hereditary hemochromatosis

  Cortés, P., Elsayed, A. A., Stancampiano, F. F., Barusco, F. M., Shapiro, B. P., Bi, Y., Heckman, M. G., Peng, Z., Kempaiah, P. & Palmer, W. C., Jan 2024, In: International Journal of Cardiovascular Imaging. 40, 1, p. 45-53 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Hemochromatosis 100%
  • Echocardiography 66%
  • Stroke Volume 60%
  • Mutation 44%
  • Myocardial Infarction 28%

• Clinical Characteristics and Outcomes in Young-Onset Multiple System Atrophy

  Badihian, N., Savica, R., Adler, C. H., Wszolek, Z. K., Jackson, L. M., Benarroch, E. E., Sandroni, P., Low, P. A., Singer, W. & Coon, E. A., Mar 2024, In: Movement Disorders Clinical Practice. 11, 3, p. 220-226 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Multiple System Atrophy 100%
  • Survival 8%
  • Medical Records 8%
  • Phenotype 6%
  • Parkinsonian Disorders 5%

• Clinical Outcomes After Stereotactic Body Radiation Therapy for Nonspinal Bone Metastases: A Systematic Review and Meta-analysis

  Singh, R., Valluri, A., Lehrer, E. J., Cao, Y., Upadhyay, R., Trifiletti, D. M., Lo, S. S., Redmond, K. J., Sahgal, A., Nguyen, Q. N. & Palmer, J. D., 2024, (Accepted/In press) In: International Journal of Radiation Oncology Biology Physics.

  Research output: Contribution to journal › Review article › peer-review

  • metastasis 100%
  • Radiosurgery 75%
  • radiation therapy 69%
  • bones 67%
  • Meta-Analysis 51%

• Clinical outcomes of atezolizumab versus standard-of-care docetaxel with and without ramucirumab in patients with advanced non-small-cell lung cancer who received prior immunotherapy

  Li, S., Manochakian, R., Chen, R., Patel, J., Inampudi, J. V., Hiren, K. R., Zhao, Y. & Lou, Y., 2024, In: Frontiers in Oncology. 14, 1306311.

  Research output: Contribution to journal › Article › peer-review

  Open Access

• Clinical presentation and diagnosis of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia: a literature analysis of case studies

  Papapetropoulos, S., Gelfand, J. M., Konno, T., Ikeuchi, T., Pontius, A., Meier, A., Foroutan, F. & Wszolek, Z. K., 2024, In: Frontiers in Neurology. 15, 1320663.

  Research output: Contribution to journal › Article › peer-review

  Open Access

• Clinical Utility of the Standardized Word Recognition Score

  Zapala, D. A., Stamper, G. C., Bogle, J. M., Jagger, S. L. & Lundy, L. B., Jan 1 2024, In: Ear and hearing. 45, 1, p. 94-105 12 p.

  Research output: Contribution to journal › Article › peer-review

  • Psychology Recognition 100%
  • Neoplasms 36%
  • Retrocochlear Diseases 34%
  • Hearing Loss 27%
  • Audiology 26%

• Clinicopathologic features of a novel star-shaped transactive response DNA-binding protein 43 (TDP-43) pathology in the oldest old

  Carlos, A. F., Sekiya, H., Koga, S., Gatto, R. G., Casey, M. C., Pham, N. T. T., Sintini, I., Machulda, M. M., Jack, C. R., Lowe, V. J., Whitwell, J. L., Petrucelli, L., Reichard, R. R., Petersen, R. C., Dickson, D. W. & Josephs, K. A., Jan 1 2024, In: Journal of Neuropathology and Experimental Neurology. 83, 1, p. 36-52 17 p.

  Research output: Contribution to journal › Article › peer-review

  • Aged, 80 and over 100%
  • DNA-Binding Proteins 91%
  • Pathology 51%
  • Amygdala 13%
  • Neuroimaging 12%

• Commentary

  Kumbhari, V., Jan 30 2024, In: Endoscopy. 56, 2, p. 156 1 p.

  Research output: Contribution to journal › Comment/debate › peer-review

  Open Access

• Commonly disrupted pathways in brain and kidney in a pig model of systemic endotoxemia

  Olney, K. C., de Ávila, C., Todd, K. T., Tallant, L. E., Barnett, J. H., Gibson, K. A., Hota, P., Pandiane, A. S., Durgun, P. C., Serhan, M., Wang, R., Lind, M. L., Forzani, E., Gades, N. M., Thomas, L. F. & Fryer, J. D., Dec 2024, In: Journal of Neuroinflammation. 21, 1, 9.

  Research output: Contribution to journal › Article › peer-review

  Open Access

• Community Engagement Strategies for Underrepresented Racial and Ethnic Populations

  Odedina, F. T., Wieland, M. L., Barbel-Johnson, K. & Crook, J. M., Jan 2024, In: Mayo Clinic proceedings. 99, 1, p. 159-171 13 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

• Convergence of coronary artery disease genes onto endothelial cell programs

  Schnitzler, G. R., Kang, H., Fang, S., Angom, R. S., Lee-Kim, V. S., Ma, X. R., Zhou, R., Zeng, T., Guo, K., Taylor, M. S., Vellarikkal, S. K., Barry, A. E., Sias-Garcia, O., Bloemendal, A., Munson, G., Guckelberger, P., Nguyen, T. H., Bergman, D. T., Hinshaw, S., Cheng, N., & 7 othersCleary, B., Aragam, K., Lander, E. S., Finucane, H. K., Mukhopadhyay, D., Gupta, R. M. & Engreitz, J. M., Feb 22 2024, In: Nature. 626, 8000, p. 799-807 9 p.

  Research output: Contribution to journal › Article › peer-review

• CREST-2 reaches a surgical milestone

  Lal, B. K., Brott, T. G., Edwards, L. J. & Meschia, J. F., Feb 2024, In: Journal of vascular surgery. 79, 2, p. 195-197.e2

  Research output: Contribution to journal › Article › peer-review

• CRISPR screening identifies BET and mTOR inhibitor synergy in cholangiocarcinoma through serine glycine one carbon

  Zhu, Y., Zhang, D., Shukla, P., Jung, Y. H., Malgulwar, P. B., Chagani, S., Colic, M., Benjamin, S., Copland, J. A., Tan, L., Lorenzi, P. L., Javle, M., Huse, J. T., Roszik, J., Hart, T. & Kwong, L. N., Jan 2024, In: JCI Insight. 9, 2, e174220.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Cholangiocarcinoma 100%
  • Clustered Regularly Interspaced Short Palindromic Repeats 99%
  • Glycine 87%
  • Carbon 85%
  • Serine 83%

• Cryptic exon inclusion is a molecular signature of LATE-NC in aging brains

  Chung, M., Carter, E. K., Veire, A. M., Dammer, E. B., Chang, J., Duong, D. M., Raj, N., Bassell, G. J., Glass, J. D., Gendron, T. F., Nelson, P. T., Levey, A. I., Seyfried, N. T. & McEachin, Z. T., Jun 2024, In: Acta neuropathologica. 147, 1

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Brain Diseases 100%
  • Exons 87%
  • Brain 51%
  • Alzheimer Disease 34%
  • RNA 31%

• Cryptic splicing of stathmin-2 and UNC13A mRNAs is a pathological hallmark of TDP-43-associated Alzheimer’s disease

  Agra Almeida Quadros, A. R., Li, Z., Wang, X., Ndayambaje, I. S., Aryal, S., Ramesh, N., Nolan, M., Jayakumar, R., Han, Y., Stillman, H., Aguilar, C., Wheeler, H. J., Connors, T., Lopez-Erauskin, J., Baughn, M. W., Melamed, Z., Beccari, M. S., Olmedo Martínez, L., Canori, M., Lee, C. Z., & 10 othersMoran, L., Draper, I., Kopin, A. S., Oakley, D. H., Dickson, D. W., Cleveland, D. W., Hyman, B. T., Das, S., Ertekin-Taner, N. & Lagier-Tourenne, C., Jun 2024, In: Acta neuropathologica. 147, 1, 9.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Stathmin 100%
  • Alzheimer Disease 50%
  • Messenger RNA 36%
  • Amyotrophic Lateral Sclerosis 27%
  • TDP-43 Proteinopathies 22%

• CSF1R-related disorder: State of the art, challenges, and proposition of a new terminology

  Dulski, J., Muthusamy, K., Lund, T. C. & Wszolek, Z. K., Apr 2024, In: Parkinsonism and Related Disorders. 121, 105894.

  Research output: Contribution to journal › Review article › peer-review

  • Terminology 100%
  • Neuroglia 87%
  • Dysosteosclerosis 70%
  • Phenotype 59%
  • Genotype 47%

• Daratumumab-lenalidomide and daratumumab-pomalidomide in relapsed lenalidomide-exposed or refractory multiple myeloma

  Alhaj Moustafa, M., Parrondo, R., Abdulazeez, M. F., Roy, V., Sher, T., Alegria, V. R., Warsame, R. M., Fonseca, R., Rasheed, A., Gonsalves, W. I., Kourelis, T., Kapoor, P., Buadi, F. K., Dingli, D., Hayman, S. R., Reeder, C. B., Chanan-Khan, A. A. & Ailawadhi, S., Jan 1 2024, In: Anti-cancer drugs. 35, 1, p. 63-69 7 p.

  Research output: Contribution to journal › Article › peer-review

  • daratumumab 100%
  • pomalidomide 95%
  • Lenalidomide 78%
  • Multiple Myeloma 58%
  • Dexamethasone 30%

• Demographic, clinical, biomarker, and neuropathological correlates of posterior cortical atrophy: an international cohort study and individual participant data meta-analysis

  PCA International Work Group, Feb 2024, In: The Lancet Neurology. 23, 2, p. 168-177 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Atrophy 100%
  • Data Analysis 85%
  • Meta-Analysis 85%
  • Cohort Studies 78%
  • Biomarkers 74%

• Diagnostic Utility of Cerebrospinal Fluid Biomarkers in Patients with Rapidly Progressive Dementia

  Kuchenbecker, L. A., Tipton, P. W., Martens, Y., Brier, M. R., Satyadev, N., Dunham, S. R., Lazar, E. B., Dacquel, M. V., Henson, R. L., Bu, G., Geschwind, M. D., Morris, J. C., Schindler, S. E., Herries, E., Graff-Radford, N. R. & Day, G. S., Feb 2024, In: Annals of neurology. 95, 2, p. 299-313 15 p.

  Research output: Contribution to journal › Article › peer-review

  • Cerebrospinal Fluid 100%
  • Dementia 96%
  • Biomarkers 74%
  • Neurocalcin 41%
  • Neurodegenerative Diseases 39%

• Discrete class i molecules on brain endothelium differentially regulate neuropathology in experimental cerebral malaria

  Fain, C. E., Zheng, J., Jin, F., Ayasoufi, K., Wu, Y., Lilley, M. T., Dropik, A. R., Wolf, D. M., Rodriguez, R. C., Aibaidula, A., Tritz, Z. P., Bouchal, S. M., Pewe, L. L., Urban, S. L., Chen, Y., Chang, S. Y., Hansen, M. J., Kachergus, J. M., Shi, J., Thompson, E. A., & 6 othersJensen, H. E., Harty, J. T., Parney, I. F., Sun, J., Wu, L. J. & Johnson, A. J., Feb 1 2024, In: Brain. 147, 2, p. 566-589 24 p.

  Research output: Contribution to journal › Article › peer-review

  • Cerebral Malaria 100%
  • Neuropathology 81%
  • Endothelium 64%
  • T-Lymphocytes 38%
  • Brain 35%

• Disparate Dementia Risk Factors Are Associated with Cognitive Impairment and Rates of Decline in African Americans

  Lachner, C., Craver, E. C., Babulal, G. M., Lucas, J. A., Ferman, T. J., White, R. O., Graff-Radford, N. R. & Day, G. S., Mar 2024, In: Annals of neurology. 95, 3, p. 518-529 12 p.

  Research output: Contribution to journal › Article › peer-review

  • African Americans 100%
  • Dementia 89%
  • Cognitive Dysfunction 87%
  • Confidence Intervals 36%
  • Mental Status and Dementia Tests 31%